Politics

Senator: White House Drug Office Promises Objective Cannabis Study

Published on October 3, 2018 · Last updated July 28, 2020
(lucky-photographer/iStock)

A White House drug office official has offered assurances that a marijuana policy panel will be objective and dispassionate as it examines the impact of legalization in some states, a Colorado senator said.

The vow came after BuzzFeed reported in August that the panel intended to portray marijuana as a national threat and criticize state efforts to legalize it drug.

The committee had asked 14 federal agencies and the DEA to submit ‘data demonstrating the most significant negative trends’ about marijuana and its national ‘threats.’

Democratic U.S. Sen. Michael Bennet disclosed the assurances Monday after he asked the Executive Office of the President’s Office of National Drug Control Policy to respond to the report.

BuzzFeed said the committee had asked 14 federal agencies and the Drug Enforcement Administration to submit “data demonstrating the most significant negative trends” about marijuana and its national “threats.”

The online news site based its reporting on documents it had obtained.

James Carroll, deputy director of the drug office, told the senator the committee would use scientific data in its study of the drug, which is broadly legal in Colorado, Bennett said.

Most US States Already Have Legal CannabisThe drug office’s media relations representatives didn’t respond to an email seeking comment late Tuesday.

Colorado was one of the first two states to legalize marijuana and it now has a growing cannabis industry.

“In Colorado, we’ve made a deliberate effort to ensure fact-based data informs our marijuana policies,” Bennet said. “Government-sponsored propaganda shouldn’t undermine that effort.”

Shop highly rated dispensaries near you

Showing you dispensaries near
See all dispensaries
The Associated Press
The Associated Press
The AP is one of the world's largest and most trusted sources of independent newsgathering.
View The Associated Press's articles
Get good reads, local deals, and strain spotlights delivered right to your inbox.

By providing us with your email address, you agree to Leafly's Terms of Service and Privacy Policy.



Stay In Touch

Receive updates on new products, special offers, and industry news.

By providing us with your email address, you agree to Leafly's Terms of Service and Privacy Policy.

Leafly mobile app
Get high for less.
Download the Leafly app.
Download Leafly: Marijuana Reviews on the App Store
Download Leafly Marijuana Reviews on Google Play




* Statements made on this website have not been evaluated by the U.S. Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease. Information provided by this website or this company is not a substitute for individual medical advice.


© 2024 Leafly, LLC
Leafly and the Leafly logo are registered trademarks of Leafly, LLC. All Rights Reserved.